Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


06.02.2017

1 Arch Phys Med Rehabil
1 BMC Neurol
1 J Immunol
7 J Neurol Sci
3 Mult Scler
3 Neurology
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Phys Med Rehabil

  1. HAMEAU S, Bensmail D, Roche N, Zory R, et al
    Fatigability in patients with multiple sclerosis during maximal concentric contractions.
    Arch Phys Med Rehabil. 2017 Jan 24. pii: S0003-9993(17)30024.
    PubMed     Text format     Abstract available


    BMC Neurol

  2. SAIDA T, Itoyama Y, Kikuchi S, Hao Q, et al
    Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study.
    BMC Neurol. 2017;17:17.
    PubMed     Text format     Abstract available


    J Immunol

  3. NEGROTTO L, Correale J
    Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.
    J Immunol. 2017 Jan 27. pii: 1601139. doi: 10.4049/jimmunol.1601139.
    PubMed     Text format     Abstract available


    J Neurol Sci

  4. ZAHOOR I, Haq E, Asimi R
    Multiple sclerosis in Kashmir: Where we stand.
    J Neurol Sci. 2017;373:129-133.
    PubMed     Text format     Abstract available

  5. NOCITI V, Losavio FA, Gnoni V, Losurdo A, et al
    Response to the letter to the Editor for the manuscript "Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study" by Tomoyuki Kawada.
    J Neurol Sci. 2017;373:142.
    PubMed     Text format    

  6. KAWADA T
    Poor sleep and fatigue in patients with multiple sclerosis.
    J Neurol Sci. 2017;373:143.
    PubMed     Text format    

  7. FERREIRA KP, Oliveira SR, Kallaur AP, Kaimen-Maciel DR, et al
    Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis.
    J Neurol Sci. 2017;373:236-241.
    PubMed     Text format     Abstract available

  8. LANGESKOV-CHRISTENSEN M, Bisson EJ, Finlayson ML, Dalgas U, et al
    Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: A scoping review.
    J Neurol Sci. 2017;373:307-320.
    PubMed     Text format     Abstract available

  9. WUNDES A, Bowen JD, Kraft GH, Maravilla KR, et al
    Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    J Neurol Sci. 2017;373:339-341.
    PubMed     Text format     Abstract available

  10. ZHOU Y, Fang L, Peng L, Qiu W, et al
    TLR9 and its signaling pathway in multiple sclerosis.
    J Neurol Sci. 2017;373:95-99.
    PubMed     Text format     Abstract available


    Mult Scler

  11. HEMPEL S, Graham GD, Fu N, Estrada E, et al
    A systematic review of the effects of modifiable risk factor interventions on the progression of multiple sclerosis.
    Mult Scler. 2017 Feb 1:1352458517690271. doi: 10.1177/1352458517690271.
    PubMed     Text format     Abstract available

  12. HEMPEL S, Graham GD, Fu N, Estrada E, et al
    A systematic review of modifiable risk factors in the progression of multiple sclerosis.
    Mult Scler. 2017 Feb 1:1352458517690270. doi: 10.1177/1352458517690270.
    PubMed     Text format     Abstract available

  13. DE STEFANO N, Giorgio A, Battaglini M, De Leucio A, et al
    Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
    Mult Scler. 2017 Jan 1:1352458517690269. doi: 10.1177/1352458517690269.
    PubMed     Text format     Abstract available


    Neurology

  14. BENNETT SE
    Fampridine: Long-term benefits in walking in multiple sclerosis.
    Neurology. 2017 Feb 1. pii: 10.1212/WNL.0000000000003677.
    PubMed     Text format    

  15. FILLI L, Zorner B, Kapitza S, Reuter K, et al
    Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.
    Neurology. 2017 Feb 1. pii: 10.1212/WNL.0000000000003656.
    PubMed     Text format     Abstract available

  16. BODINI B, Calabresi PA
    From neurofilament research to multiple sclerosis clinical practice: Where do we stand?
    Neurology. 2017 Feb 1. pii: 10.1212/WNL.0000000000003676.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  17. LIU G, Hu Y, Jin S, Jiang Q, et al
    Genetic variant rs763361 regulates multiple sclerosis CD226 gene expression.
    Proc Natl Acad Sci U S A. 2017 Jan 30. pii: 201618520.
    PubMed     Text format    

  18. GROSS CC, Meyer Zu Horste G, Schulte-Mecklenbeck A, Klotz L, et al
    Reply to Liu et al.: Haplotype matters: CD226 polymorphism as a potential trigger for impaired immune regulation in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2017 Jan 30. pii: 201619059.
    PubMed     Text format    

  19. LENGFELD JE, Lutz SE, Smith JR, Diaconu C, et al
    Endothelial Wnt/beta-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2017 Jan 30. pii: 201609905.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: